 Amgen Inc. said it plans to reduce its global workforce by 12% to 15% and close facilities in two states as part of a restructuring that aims to focus resources on developing new drugs.. The company was a biotechnology pioneer and is the largest biotech by sales. But the products that propelled its growth are aging and some are facing the threat of low-cost competition. In announcing cost-cutting plans Tuesday, Amgen joins the ranks of Big Pharmas that have been laying off employees and closing plants. It had already emulated...
  